<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-1-02-a</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-1-1-3</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Paroxysmal Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Carbamazepine - Exacerbated Epilepsy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>06</month>
<year>1987</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>08</month>
<year>2016</year>
</pub-date>
<volume>1</volume>
<issue>1</issue>
<fpage>2</fpage>
<lpage>2</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1987 The Author(s)</copyright-statement>
<copyright-year>1987</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1016/0887-8994(86)90074-3" vol="2" page="340">
<article-title>Carbamazepine-exacerbated epilepsy in children and adolescents</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Reporting from Denver, Colorado, the authors studied 49 children and adolescents whose seizures reportedly worsened during carbamazepine (CBZ) therapy.</p>
</abstract>
<kwd-group>
<kwd>Carbamazepine</kwd>
<kwd>Therapeutic Dose Levels</kwd>
<kwd>Severe Myoclonic Epilepsy</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Reporting from Denver, Colorado, the authors studied 49 children and adolescents whose seizures reportedly worsened during carbamazepine (CBZ) therapy. In 26 well documented cases, the drug at therapeutic dose levels induced exacerbation of absence, atonic myoclonic and generalized tonic-clonic seizure patterns. The effect was dose-related in 10 patients. Three of 11 patients who had their first absence seizure when CBZ was introduced developed absence status. In addition to childhood absence, the epileptic syndromes worsened by CBZ included focal symptomatic (frontal lobe), Lennox-Gastaut, and severe myoclonic epilepsy of childhood. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p><underline>COMMENT</underline>: This is the sixth report concerning seizures induced or exacerbated by carbamazepine. Partial complex seizures are frequently responsive but absence, generalised tonic-clonic, focal, or myoclonic epilepsies may be worsened by CBZ. A slow withdrawal of the CBZ results in improved seizure control.</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horn</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Ater</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Hurst</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>Carbamazepine-exacerbated epilepsy in children and adolescents</article-title>
<source>Pediatr Neurol</source>
<year>1986</year>
<month>Nov-Dec</month>
<volume>2</volume>
<issue>6</issue>
<fpage>340</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/0887-8994(86)90074-3</pub-id>
<pub-id pub-id-type="pmid">3508708</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>